- Those in the treated group spent 24 percent fewer days in the hospital and 74 percent fewer days in the ICU than those taking the placebo.
- Mortality was lower in the azithromycin group than in the placebo arm: 2 percent vs. 4 percent.
- Treatment benefits were more apparent among non-smokers; there was little or no benefit derived by current smokers from low-dose azithromycin.
Azithromycin may reduce treatment failure in acute COPD exacerbations
Published on : Wed, 8 May 2019
Medos customized tubing sets have been individually designed, so that all customer requirements, depending on application and need can be realized. Furthermore tubing sets can be refined by rheoparin or x.eed coating.
The HAMILTON-C1 neo is a versatile neonatal ventilator that combines invasive and noninvasive modes with the additional options of nCPAP and high flow oxygen therapy. The integrated turbine allows it to be operated independently of a compressed air supply....
The HAMILTON-C3 ventilator is a modular high-end ventilation solution for all patient groups. Offering a number of unique features, the HAMILTON-C3 is one of the first ventilators featuring the “Ventilation Autopilot” INTELLiVENT-ASV®. The HAMILTON-C3’s...
The HAMILTON-G5 is Hamilton Medical’s most modular high-end mechanical ventilator. A wide range of standard features and options allows you to tailor the HAMILTON-G5 to your needs. · Automated control of the patient’s ventilation a
XENIOS AG – a Fresenius Medical Care company – unites two brands under one umbrella, Novalung and Medos. The Novalung and Medos products offer the full range of heart and lung support on one single platform: the Xenios console. This console enables next-generation...